Trade-off ofmyocardial infarction vs. bleeding types onmortality after acute coronary syndrome: Lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial

Marco Valgimigli, Francesco Costa, Yuliya Lokhnygina, Robert M. Clare, Lars Wallentin, David J. Moliterno, Paul W. Armstrong, Harvey D. White, Claes Held, Philip E. Aylward, Frans Van DeWerf, Robert A. Harrington, Kenneth W. Mahaffey, Pierluigi Tricoci

Research output: Contribution to journalArticlepeer-review

253 Scopus citations

Fingerprint

Dive into the research topics of 'Trade-off ofmyocardial infarction vs. bleeding types onmortality after acute coronary syndrome: Lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science